Trial intelligence / Profile preview

Effects of suvorexant on energy metabolism and sleep architecture in healthy men

jRCTs031210023Completed

Sponsor
Japan Society for the Promotion of Science
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial comparing Suvorexant 20 mg sequence with Placebo sequence (2 arms). Primary endpoint: Primary: Effect of suvorexant on 8-hour sleep energy metabolism. Started Jun 2021; status: completed.

02

Drugs

suvorexant

Beyond the preview

Go deeper on jRCTs031210023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031210023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call